Analysen zu GSK PLC Registered Shs
| 02.07.24 | GSK Buy | Jefferies & Company Inc. | |
| 02.07.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.07.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 27.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 27.06.24 | GSK Buy | UBS AG | |
| 19.06.24 | GSK Buy | Deutsche Bank AG | |
| 18.06.24 | GSK Buy | UBS AG | |
| 18.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 18.06.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 17.06.24 | GSK Buy | Jefferies & Company Inc. | |
| 10.06.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 07.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 04.06.24 | GSK Halten | DZ BANK | |
| 04.06.24 | GSK Buy | UBS AG | |
| 04.06.24 | GSK Buy | Deutsche Bank AG | |
| 03.06.24 | GSK Buy | Jefferies & Company Inc. | |
| 03.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.06.24 | GSK Buy | Deutsche Bank AG | |
| 03.06.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 30.05.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 13.05.24 | GSK Buy | Deutsche Bank AG | |
| 13.05.24 | GSK Buy | Jefferies & Company Inc. | |
| 08.05.24 | GSK Outperform | Bernstein Research | |
| 06.05.24 | GSK Buy | UBS AG | |
| 03.05.24 | GSK Halten | DZ BANK | |
| 02.05.24 | GSK Buy | Deutsche Bank AG | |
| 02.05.24 | GSK Buy | UBS AG | |
| 02.05.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.24 | GSK Buy | UBS AG | |
| 01.05.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.04.24 | GSK Buy | UBS AG | |
| 24.04.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 24.04.24 | GSK Outperform | Bernstein Research | |
| 08.04.24 | GSK Equal Weight | Barclays Capital | |
| 04.04.24 | GSK Equal Weight | Barclays Capital | |
| 03.04.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 20.03.24 | GSK Buy | Jefferies & Company Inc. | |
| 19.03.24 | GSK Buy | UBS AG | |
| 18.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.03.24 | GSK Buy | UBS AG | |
| 27.02.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.02.24 | GSK Buy | Deutsche Bank AG | |
| 15.02.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.02.24 | GSK Buy | UBS AG | |
| 09.02.24 | GSK Buy | Jefferies & Company Inc. | |
| 08.02.24 | GSK Buy | Deutsche Bank AG | |
| 06.02.24 | GSK Buy | UBS AG | |
| 05.02.24 | GSK Buy | Deutsche Bank AG |
Aktuelle Aktienanalysen
| 21.11.24 | NVIDIA Halten | DZ BANK | |
| 21.11.24 | Symrise Overweight | JP Morgan Chase & Co. | |
| 21.11.24 | Lenzing neutral | Deutsche Bank AG | |
| 21.11.24 | Airbus Hold | Deutsche Bank AG | |
| 21.11.24 | STMicroelectronics Buy | Deutsche Bank AG | |
| 21.11.24 | Nestlé Hold | Deutsche Bank AG | |
| 21.11.24 | Symrise Buy | UBS AG | |
| 21.11.24 | freenet Buy | Deutsche Bank AG | |
| 21.11.24 | Philips Overweight | Barclays Capital | |
| 21.11.24 | Siemens Healthineers Overweight | Barclays Capital | |
| 21.11.24 | Medios Buy | Deutsche Bank AG | |
| 21.11.24 | NVIDIA Hold | Deutsche Bank AG | |
| 21.11.24 | NVIDIA Buy | UBS AG | |
| 21.11.24 | Frequentis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.11.24 | Fresenius Overweight | Barclays Capital | |
| 21.11.24 | Fresenius Medical Care Equal Weight | Barclays Capital | |
| 21.11.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.11.24 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 21.11.24 | CTS Eventim Overweight | JP Morgan Chase & Co. | |
| 21.11.24 | CTS Eventim Add | Baader Bank | |
| 21.11.24 | CTS Eventim Buy | Jefferies & Company Inc. | |
| 21.11.24 | Novartis Underweight | Barclays Capital | |
| 21.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 21.11.24 | CTS Eventim Outperform | Bernstein Research | |
| 21.11.24 | Rheinmetall Buy | Deutsche Bank AG | |
| 21.11.24 | Novartis Buy | UBS AG | |
| 21.11.24 | Richemont Outperform | Bernstein Research | |
| 21.11.24 | EssilorLuxottica Market-Perform | Bernstein Research | |
| 21.11.24 | Kering Market-Perform | Bernstein Research | |
| 21.11.24 | LVMH Moet Hennessy Louis Vuitton Outperform | Bernstein Research | |
| 21.11.24 | Vestas Wind Systems A-S Outperform | Bernstein Research | |
| 21.11.24 | Symrise Hold | Jefferies & Company Inc. | |
| 21.11.24 | ASML NV Outperform | Bernstein Research | |
| 21.11.24 | NVIDIA Overweight | JP Morgan Chase & Co. | |
| 21.11.24 | SMA Solar Hold | Jefferies & Company Inc. | |
| 21.11.24 | PVA TePla Hold | Jefferies & Company Inc. | |
| 21.11.24 | VERBIO Vereinigte BioEnergie Buy | Jefferies & Company Inc. | |
| 21.11.24 | Sixt Buy | Jefferies & Company Inc. | |
| 21.11.24 | Siemens Healthineers Buy | Jefferies & Company Inc. | |
| 21.11.24 | Unilever Sell | UBS AG | |
| 21.11.24 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 21.11.24 | Porsche Buy | Goldman Sachs Group Inc. | |
| 21.11.24 | STMicroelectronics Neutral | Goldman Sachs Group Inc. | |
| 21.11.24 | NVIDIA Outperform | Bernstein Research | |
| 21.11.24 | NVIDIA Buy | Goldman Sachs Group Inc. | |
| 21.11.24 | Bayer Neutral | UBS AG | |
| 20.11.24 | STMicroelectronics Buy | UBS AG | |
| 20.11.24 | Symrise Buy | UBS AG | |
| 20.11.24 | Symrise Hold | Jefferies & Company Inc. | |
| 20.11.24 | Daimler Truck Buy | Jefferies & Company Inc. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.